Adverse consequences of immediate thrombolysis-related complications: a multi-centre registry-based cohort study of acute stroke.


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
Jan 2022
Historique:
accepted: 27 06 2021
pubmed: 14 7 2021
medline: 7 4 2022
entrez: 13 7 2021
Statut: ppublish

Résumé

Complications following thrombolysis for stroke are well documented, and mostly concentrated on haemorrhage. However, the consequences of patients who experience any immediate thrombolysis-related complications (TRC) compared to patients without immediate TRC have not been examined. Prospectively collected data from the Sentinel Stroke National Audit Programme were analysed. Thrombolysis was performed in 451 patients (52.1% men; 75.3 years ± 13.2) admitted with acute ischaemic stroke (AIS) in four UK centres between 2014 and 2016. Adverse consequences following immediate TRC were assessed using logistic regression, adjusted for age, sex and co-morbidities. Twenty-nine patients (6.4%) acquired immediate TRC. Compared to patients without, individuals with immediate TRC had greater adjusted risks of: moderately-severe or severe stroke (National Institutes of Health for Stroke Scale score ≥ 16) at 24-h (5.7% vs 24.7%, OR 3.9, 95% CI 1.4-11.1); worst level of consciousness (LOC) in the first 7 days (score ≥ 1; 25.0 vs 60.7, OR 4.6, 95% CI 2.1-10.2); urinary tract infection or pneumonia within 7-days of admission (13.5% vs 39.3%, OR 3.2, 95% CI 1.3-7.7); length of stay (LOS) on hyperacute stroke unit (HASU) ≥ 2 weeks (34.7% vs 66.7%, OR 5.2, 95% CI 1.5-18.4); mortality (13.0% vs 41.4%, OR 3.7, 95% CI 1.6-8.4); moderately-severe or severe disability (modified Rankin Scale  score ≥ 4) at discharge (26.8% vs 65.5%, OR 4.7, 95% CI 2.1-10.9); palliative care by discharge date (5.1% vs 24.1%, OR 5.1, 95% CI 1.7-15.7). The median LOS on the HASU was longer (7 days vs 30 days, Kruskal-Wallis test: χ

Identifiants

pubmed: 34255266
doi: 10.1007/s11239-021-02523-2
pii: 10.1007/s11239-021-02523-2
pmc: PMC8791861
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-227

Informations de copyright

© 2021. The Author(s).

Références

Cerebrovasc Dis. 2003;16(3):183-90
pubmed: 12865603
BMJ. 2010 Nov 23;341:c6046
pubmed: 21098614
J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1127-36
pubmed: 25814492
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Lancet. 2017 Apr 1;389(10076):1323-1335
pubmed: 28236464
JAMA Neurol. 2014 Sep;71(9):1181-5
pubmed: 25069522
Stroke. 2020 Feb;51(2):594-600
pubmed: 31842700
BMJ Open. 2018 Jul 11;8(7):e022558
pubmed: 29997144
Stroke. 2004 Jul;35(7):1671-6
pubmed: 15166391
Stroke. 2012 Jun;43(6):1524-31
pubmed: 22442178
J Hosp Med. 2010 Sep;5(7):406-9
pubmed: 20578049
Lancet. 2009 Oct 3;374(9696):1196-208
pubmed: 19801098
J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):70-5
pubmed: 15607998
Neurocrit Care. 2012 Aug;17(1):107-11
pubmed: 22311234
Eur J Intern Med. 2016 Apr;29:9-21
pubmed: 26723523
Stroke. 2012 Sep;43(9):2293-9
pubmed: 22811458
Stroke. 2020 Aug;51(8):2536-2539
pubmed: 32586222
Stroke. 2001 Feb;32(2):438-41
pubmed: 11157179
Age Ageing. 2013 Mar;42(2):240-5
pubmed: 23174425
J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1093-9
pubmed: 18223014
Stroke. 2017 Dec;48(12):e343-e361
pubmed: 29097489
Neurology. 2001 Aug 14;57(3):474-80
pubmed: 11502916
Stroke. 2012 May;43(5):1315-22
pubmed: 22308252
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
Stroke. 2013 Mar;44(3):870-947
pubmed: 23370205
Lancet. 2014 Nov 29;384(9958):1929-35
pubmed: 25106063
Neurol Sci. 2019 Aug;40(8):1659-1665
pubmed: 31030369
BMC Neurol. 2018 Oct 3;18(1):164
pubmed: 30285659
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):543-9
pubmed: 24046398
Neurology. 2005 Dec 13;65(11):1795-8
pubmed: 16221951
Seizure. 2018 Nov;62:91-94
pubmed: 30312935
Clin Med (Lond). 2017 Apr;17(2):161-165
pubmed: 28365630
Circulation. 2002 Apr 9;105(14):1679-85
pubmed: 11940547
Age Ageing. 2006 Nov;35(6):572-80
pubmed: 17047006
Stroke. 2016 Feb;47(2):581-641
pubmed: 26696642
Stroke. 2002 Sep;33(9):2236-42
pubmed: 12215593
Arch Neurol. 2010 Aug;67(8):965-9
pubmed: 20697046
Stroke. 2004 Sep;35(9):2123-7
pubmed: 15243150
Lancet. 2012 Jun 23;379(9834):2364-72
pubmed: 22632907
Stroke. 2010 Nov;41(11):2568-74
pubmed: 20930163
Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1478-1484
pubmed: 29565510
Stroke. 1989 Jul;20(7):864-70
pubmed: 2749846

Auteurs

Thang S Han (TS)

Institute of Cardiovascular Research, Royal Holloway University of London, Egham, TW20 0EX, UK. thang.han@rhul.ac.uk.

Giosue Gulli (G)

Department of Stroke, Ashford and St Peter's NHS Foundation Trust, Chertsey, GU9 0PZ, UK.

Christopher H Fry (CH)

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK.

Brendan Affley (B)

Department of Stroke, Ashford and St Peter's NHS Foundation Trust, Chertsey, GU9 0PZ, UK.

Jonathan Robin (J)

Department of Acute Medicine, Ashford and St Peter's NHS Foundation Trust, Chertsey, GU9 0PZ, UK.

David Fluck (D)

Department of Cardiology, Ashford and St Peter's NHS Foundation Trust, Chertsey, GU9 0PZ, UK.

Puneet Kakar (P)

Department of Stroke, Epsom and St Helier University Hospitals, Epsom, KT18 7EG, UK.

Pankaj Sharma (P)

Institute of Cardiovascular Research, Royal Holloway University of London, Egham, TW20 0EX, UK.
Department of Clinical Neuroscience, Imperial College Healthcare NHS Trust, London, W6 8RF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH